CARM1 hypermethylates the NuRD chromatin remodeling complex to promote cell cycle gene expression and breast cancer development
Nucleic Acids Research · 08.07.2024 · 52 (12) · 6811-6829
DOI: 10.1093/nar/gkae329 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 27.04.2024. Verfasst von Xue Chen und 15 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiang'a…. Hauptthemen laut MEDLINE: Mi-2 Nucleosome Remodeling and Deacetylase Complex, Protein-Arginine N-Methyltransferases, Breast Neoplasms, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Natural Science Foundation of Fujian Province of China.
Abstract (Originalsprache)
Protein arginine methyltransferase CARM1 has been shown to methylate a large number of non-histone proteins, and play important roles in gene transcriptional activation, cell cycle progress, and tumorigenesis. However, the critical substrates through which CARM1 exerts its functions remain to be fully characterized. Here, we reported that CARM1 directly interacts with the GATAD2A/2B subunit in the nucleosome remodeling and deacetylase (NuRD) complex, expanding the activities of NuRD to include protein arginine methylation. CARM1 and NuRD bind and activate a large cohort of genes with implications in cell cycle control to facilitate the G1 to S phase transition. This gene activation process requires CARM1 to hypermethylate GATAD2A/2B at a cluster of arginines, which is critical for the recruitment of the NuRD complex. The clinical significance of this gene activation mechanism is underscored by the high expression of CARM1 and NuRD in breast cancers, and the fact that knockdown CARM1 and NuRD inhibits cancer cell growth in vitro and tumorigenesis in vivo. Targeting CARM1-mediated GATAD2A/2B methylation with CARM1 specific inhibitors potently inhibit breast cancer cell growth in vitro and tumorigenesis in vivo. These findings reveal a gene activation program that requires arginine methylation established by CARM1 on a key chromatin remodeler, and targeting such methylation might represent a promising therapeutic avenue in the clinic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiang'an South Road, Xiamen, Fujian 361102, China.
- Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiang'an South Road, Xiamen, Fujian 361102, China.
- Xiang An Biomedicine Laboratory, School of Pharmaceutical Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiang'an South Road, Xiamen, Fujian 361102, China.
- Department of Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, No. 23, Qingnian Road, Ganzhou, Jiangxi 341000, China.
- Xiamen University-Amogene Joint R&D Center for Genetic Diagnostics, School of Pharmaceutical Sciences, Xiang'an South Road, Xiamen, Fujian 361102, China.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Natural Science Foundation of Fujian Province of China
- Fundamental Research Funds for the Central University
- China Postdoctoral Science Foundation
Zitieren
APA
Chen, X., Huang, M. F., Fan, D. M., He, Y. H., Zhang, W. J., Ding, J. C., Peng, B. L., Pan, X., Liu, Y., Du, J., Li, Y., Liu, Z. Y., Xie, B. L., Kuang, Z. J., Yi, J., & Liu, W. (2024). CARM1 hypermethylates the NuRD chromatin remodeling complex to promote cell cycle gene expression and breast cancer development. Nucleic Acids Research, 52(12), 6811-6829. https://doi.org/10.1093/nar/gkae329
Vancouver
Chen X, Huang MF, Fan DM, He YH, Zhang WJ, Ding JC, et al. CARM1 hypermethylates the NuRD chromatin remodeling complex to promote cell cycle gene expression and breast cancer development. Nucleic Acids Research. 2024;52(12):6811-6829. doi:10.1093/nar/gkae329
BibTeX
@article{Chen2024,
author = {Chen, Xue and Huang, Ming-Feng and Fan, Da-Meng and He, Yao-Hui and Zhang, Wen-Juan and Ding, Jian-Cheng and Peng, Bing-Ling and Pan, Xu and Liu, Ya and Du, Jun and Li, Ying and Liu, Zhi-Ying and Xie, Bing-Lan and Kuang, Zhi-Jian and Yi, Jia and Liu, Wen},
title = {CARM1 hypermethylates the NuRD chromatin remodeling complex to promote cell cycle gene expression and breast cancer development},
journal = {Nucleic Acids Research},
year = {2024},
volume = {52},
number = {12},
pages = {6811--6829},
doi = {10.1093/nar/gkae329}
}
EUVIMED